Your session is about to expire
← Back to Search
Radiofrequency Ablation for Thyroid Nodules
Study Summary
This trial studies radiofrequency ablation to treat patients with benign or low-risk thyroid nodules. The goal is to learn if it is as effective as surgery and if it has a better recovery response.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Women who can have babies must have a negative pregnancy test before starting the study.I am allergic to some anesthesia medications.You have cysts with less than 70% solid material.My thyroid cancer has spread beyond the thyroid or to other parts of my body.My targeted nodule is close to major blood vessels or important nerves.Your blood tests and thyroid hormone levels are within the normal range, and you don't have specific antibodies related to thyroid issues.My benign nodule is at least 2 cm, mostly solid, and confirmed benign by tests.I want treatment for my thyroid nodule due to discomfort or appearance concerns.The entire nodule can be seen on ultrasound, and it doesn't extend too far behind the trachea or into the mediastinum.My thyroid nodule is suspicious but not clearly cancerous, or I have a small, local thyroid cancer without spread.My nodule can be reached through a specific surgical approach.I understand and agree to participate in the study.I am over 18 and cannot or will not have surgery.My thyroid cancer is of an aggressive type, confirmed by a team of specialists.Your blood does not clot properly, or your platelet count is too low.I am healthy enough for local anesthesia with or without sedation.I have a single thyroid nodule or a dominant one in a multinodular goiter.I have had radiation therapy to my neck.I have a heart rhythm problem or a device like a pacemaker.My thyroid nodules are overactive, confirmed by tests.You have calcified nodules.You have paralysis in your vocal cords on the opposite side of your body.
- Group 1: Treatment (RFA)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are enrolled in this experiment?
"Affirmative. Clinicaltrials.gov attests that this research endeavour, which was initiated on August 29th 2022 and revised September 3rd 2022, is actively recruiting participants. The trial requires 100 people to be sourced from 1 medical centre."
Does this research currently offer opportunities to participate?
"According to the details posted on clinicaltrials.gov, this medical trial is currently seeking out potential participants. It was initially uploaded on August 29th 2022 and its contents were last revised September 3rd 202"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger